ENDOTHELIAL FUNCTION IN PATIENTS WITH COPD AND CARDIOVASCULAR DISEASE (REVIEW)
Author:
Ashcheulova T.V.1ORCID, Gerasimchuk N.N.1ORCID, Kompaniiets K.N.1ORCID, Honchar O.V.1ORCID
Affiliation:
1. Kharkiv National Medical University, Kharkiv, Ukraine
Abstract
Cardiovascular pathology is one of the frequent comorbidities in patients with chronic obstructive pulmonary disease, due to both genetic predisposition and common risk factors (smoking, senile age, male gender, sedentary lifestyle, obesity). The article shows that development of endothelial dysfunction is one of the earliest phases of pathogenesis in this setting. Endothelial dysfunction mechanisms are defined and characterized, including an imbalance of vasoconstricting and vasodilating agents with the emergence of "vicious circles" that violate hemo-vascular homeostasis. The role of nitric oxide, endothelin-1, intercellular adhesion molecule-1 (ICAM-1) in the development of endothelial dysfunction in COPD patients is discussed.
The article defines the concept of oxidative stress, the most potent oxidants and mechanisms of their damaging effect arebeing listed. A particular attention is paid to 8-isoprostane as a golden standard in assessment of oxidative stress in patients with COPD.
Publisher
Kharkiv National Medical University
Reference60 articles.
1. Lopez, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A. L., Held, L. S., ... & Buist, S. (2006). Chronic obstructive pulmonary disease: current burden and future projections. European Respiratory Journal, 27(2), 397-412. doi: 10.1183/09031936.06.00025805 2. Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine, 3(11), e442. doi: 10.1371/journal.pmed.0030442 3. Trupin, L., Earnest, G., San Pedro, M., Balmes, J. R., Eisner, M. D., Yelin, E., ... & Blanc, P. D. (2003). The occupational burden of chronic obstructive pulmonary disease. European Respiratory Journal, 22(3), 462-469. doi: 10.1183/09031936.03.00094203 4. Dahl, R., Chung, K. F., Buhl, R., Magnussen, H., Nonikov, V., Jack, D., ... & Kramer, B. (2010). Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax, 65(6), 473-479. doi: 10.1136/thx.2009.125435 5. Feshhenko, Ju. I. (2009). HOZL v Ukraine: problemy i puti reshenija. Zdorov’ja Ukraїni, 9(1), 3−4 (in Russian).
|
|